Vascular endothelial growth factor inhibitors (VEGFIs) have transformed treatment paradigms for several malignancies. By ...

Background Cardiopulmonary exercise testing (CPET) is essential for assessing patients with hypertrophic cardiomyopathy (HCM) ...

Background Despite sub-optimal long-term results DC electrical cardioversion (DCCV) remains a main stay in atrial fibrillation (AF) management. In selected patients long-term success at 6 weeks is ...

BHF Health Promotion Research Group, Division of Public Health and Primary Health Care, University of Oxford, UK Dr M O’Flaherty, Division of Public Health, Whelan Building, Quadrangle, University of ...

Around 40% of all patients undergoing angiography are found to have normal coronary arteries or non-obstructive coronary artery disease (NOCAD). Despite the high prevalence, this is a group who rarely ...

Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence (continuation of drugs) ...

Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Macrophages are important components ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Correspondence to Professor Martin Ng, Department of Cardiology, The University of Sydney, Sydney, New South Wales, Australia; Martin.ng{at}sydney.edu.au Background Despite restoration of epicardial ...

Background Pulmonary hypertension (PHT) lacks community prevalence and outcome data. Objective To characterise minimum ‘indicative’ prevalences and mortality data for all forms of PHT in a selected ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

In this article, we provide a historical view of key aspects of British Cardiovascular Society (BCS) influence in clinical trials of ischaemic heart disease (IHD) followed by key research and ...